Dedifferentiated Chondrosarcoma

• CLINICAL_TRIALS research · 2025-11-21
  Clinical Trial Update: LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas [Phase 2]

  Phase 2 study of LN-145 (LN-145-S1) in relapsed or refractory ovarian cancer, triple-negative breast cancer, anaplastic thyroid cancer, oste…

• CLINICAL_TRIALS trial_result · 2023-10-23
  Clinical Trial Update: Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma [Phase 2]

  Update on a Phase 2 pediatric trial evaluating atezolizumab in 2-17 year-olds with clear cell sarcoma or advanced central chondrosarcoma, in…

• CLINICAL_TRIALS trial_result · 2022-04-20
  Clinical Trial Update: Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma [Phase 2]

  Phase 2 trial evaluating sirolimus with cyclophosphamide in metastatic or unresectable myxoid liposarcoma and chondrosarcoma has completed.

• CLINICAL_TRIALS trial_result · 2019-11-15
  Clinical Trial Update: Vismodegib in Treating Patients With Advanced Chondrosarcomas [Phase 2]

  Phase 2 clinical trial evaluating vismodegib for advanced chondrosarcomas has posted results in 2019 and is currently not recruiting.